Table 4.
Linear regression model results for the log2 fold change of B28/P28 Spike-specific T cell response.
Estimate | Standard Error | p-value | |
---|---|---|---|
Intercept | |||
-0,155 | 0,359 | 0,667 | |
Age (centralized) | |||
0,000 | 0,018 | 0,996 | |
Sex | |||
Male | Ref. | ||
Female | 0,546 | 0,190 | 0,004 |
Months between primary-booster (centralized) | |||
-0,255 | 0,299 | 0,394 | |
Vaccine combination | |||
BNT162b2/BNT162b2 | Ref. | ||
BNT162b2/mRNA-1273 | 0,711 | 0,279 | 0,011 |
mRNA-1273/BNT162b2 | -0,726 | 0,367 | 0,049 |
CMV status | |||
Negative | Ref. | ||
Positive | 0,910 | 0,252 | 0,000 |
Log fold change (B0/P28) | |||
0,552 | 0,051 | 0,000 | |
Months between primary-booster (centralized) * Age (centralized) | |||
0,018 | 0,008 | 0,027 | |
Months between primary-booster (centralized) * CMV status | |||
0,296 | 0,299 | 0,324 | |
Age (centralized) * CMV status | |||
-0,020 | 0,018 | 0,258 | |
Months between primary-booster (centralized) * Age (centralized) * CMV status | |||
-0,038 | 0,010 | 0,000 |
R2 = 0.517.
*indicates an interaction term; Ref. is reference.